Detailed information |
---|
CancerLivER ID | 2271 |
Biomarker | Peroxiredoxin 3 |
Biomarker Name/Symbol (given in Publication) | Peroxiredoxin 3 |
Biomolecule | Protein |
Subject | Human |
Degree of Validity | Significantly associated with early intrahepatic recurrence of HCC and validated on independent dataset |
Experimental Condition | Early recurrence v/s No recurrence HCC |
Cancer type | Hepatocellular carcinoma |
Regulation | Upregulated in recurrence HCC than non-recurrence HCC (with fold change 1.82) |
Level of significance | p < 0.05 |
Source | Tissue |
PMID | 17391314 |
Type of Biomarker | Prognostic |
Pathway | Antioxidant |
Cohort | Training dataset: 12 early recurrence and 15 no recurrence patients; validation dataset :6 early recurrence and 7 no recurrence patients |
Sensitivity | NA |
Specificity | NA |
Accuracy | NA |
AUC | NA |
Disease | Early recurrence v/s No recurrence HCC |
Year of Publication | 2007 |
Clinical trial | NO |
Clinical trial (NCT Number) | NA |